PATENT CLAIM ANALYSIS

Application Number: 16254163
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-07
Patent Classification: ["424", "001890"]

Abstract:
A method for detecting or ruling out renal amyloidosis in a subject is disclosed. The use of a stilbene derivative, such as florbetapir  18 F, or a phenylbenzothiazole derivative in positron emission tomography imaging, or integrated positron emission tomography/computed tomography imaging, can serve as a screening test for renal amyloidosis in a subject.

Claim (Index 16):
The method of  claim 15  wherein:\n R 4  is methylamino, \n n is 3, and \n X is  18 F.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 99.0
- Lexical Diversity: 1.59459
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13878689', '15030214', '12064146', '15320112', '15748556']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7247388621659004
- 35 USC 102 Novelty (BERT): 0.5200763011958691
- Combined Prediction Score: 0.7042726060688973
- Mean Citation Score: 224.64024
- Max Citation Score: 262.05453
- Similarity Product: 144.12857323422077

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test